Massive database maps links between brain development and mental health
A new large-scale, open data resource from the Perelman School of Medicine and collaborators helps researchers link brain development with mental health disorders. Mental health disorders such as depression, anxiety, and ADHD affect millions worldwide and contribute significantly to the global burden of disease—impacting individuals’ health and daily lives and placing a substantial strain on…
Read MoreUSC researchers use AI to uncover genetic blueprint of the brain’s largest communication bridge
The research team created a new AI-powered tool that identifies and quantifies the part of the brain that connects the hemispheres and made it public to accelerate neuroscience research around the globe.
Read MoreAfter His Own Struggles Growing Up, Professor Dedicates ADHD Research to Helping Others Thrive
Josh Langberg received a $3.2 million National Institute of Mental Health grant to explore how virtual reality can help college students with ADHD minimize distractions and stay focused
Read MoreEmotional Archaeology: Excavating the Feelings Beneath ADHD
Discovering the emotions that shape reactions and relationships in ADHD.
Read MoreReview finds no link between acetaminophen use in pregnancy and neurodevelopmental disorders
A rigorous systematic review of the present state of knowledge on the use of acetaminophen during pregnancy and the risk of specific neurodevelopmental disorders (NDDs), such as autism and ADHD, offers reassurance that acetaminophen does not increase the risk of NDDs.
Read MoreFDA Announces Nationwide Recall of ADHD Medication—Check Your Cabinets Now
Fast Facts: Sun Pharmaceutical Industries has recalled several lots of lisdexamfetamine dimesylate capsules, a generic form of Vyvanse. The FDA classified the recall as Class II, indicating a low risk of serious health consequences but potential temporary or reversible effects. Patients are advised to check their prescription bottles and contact their healthcare provider or pharmacy…
Read MoreFighting for ADHD awareness in Hong Kong is an uphill battle for social enterprise founder
Amanda Fok is the founder of Let’s Talk ADHD and ADHD Awareness Week, at which adults can get free ADHD assessments on October 25 and 26
Read MoreMajoring in economics, minoring in ADHD
My high school self wouldn’t recognize my college self. My friends joke that I’m the most “type B-type A” person they know. I always forget to submit my assignments even if I’ve done them, I leave questions blank on timed tests and my mind is constantly racing, yet I often forget everything I’m supposed to…
Read MoreCan One ADHD Pill Predict Future Treatment Outcomes?
The response of adults with ADHD to a single dose of methylphenidate (MPH) may indicate their treatment response at 2 months, according to a study published in Translational Psychiatry. Although further research is needed, the findings from this study may help clinicians choose the medication that will deliver the best outcomes for each patient.
Read MoreShort exercise intervention helps teens with ADHD manage stress
A new study published in the Journal of Affective Disorders provides evidence that a brief but structured physical exercise program can help reduce stress levels in adolescents diagnosed with attention-deficit/hyperactivity disorder. The researchers found that after just three weeks of moderate to vigorous physical activity, participants reported lower levels of stress and showed a measurable…
Read MoreMindfulness and Self-Compassion as Foundations of ADHD Care
Key points: Living with the struggles ADHD causes can lead to frustration and self doubt. ADHD often increases the volume of our inner critic. Mindfulness and self-compassion support all aspects of ADHD care, allowing for a more stable and kind ground.
Read MorePositive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD
Cingulate’s CTx-1301 shows promising phase 3 results for ADHD, offering effective once-daily dosing and potential FDA approval by 2026.
Read More